8-K
XBRL
CURRENT REPORT
- Company
- Kyverna Therapeutics, Inc.
- Filed
- June 30, 2025
- Period of Report
- June 30, 2025
- Accession Number
- 0001213900-25-059289
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →